Chemotherapy-Free pCR-Guided Strategy With Trastuzumab-pertuzumab and T-DM1 in HER2-positive Early Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Early Breast Cancer
Interventions: DRUG: Trastuzumab and Pertuzumab (FDC SC) and T-DM1
Sponsor: MedSIR
Collaborators: Hoffmann-La Roche